Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dominick Angiolillo MD, PhD

Dominick J. Angiolillo MD, PhD

Professor of Medicine; Director, Cardiovascular Research; Program Director, Interventional Cardiology Fellowship, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida

Disclosures

1. Receive(d) Payment as an Individual for Consulting Fee or Honorarium from: Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Daiichi Sankyo, The Medicines Company, AstraZeneca, Merck, Evolva, Abbott Vascular, Bayer and PLx Pharma

2. Receive(d) Payment as an Individual for Participation in Review Activities from: Johnson & Johnson, St. Jude, and Sunovion

3. Received Institutional Payments for Grants from: Bristol-Myers Squibb, Sanofi-Aventis, GlaxoSmithKline, Otsuka, Eli Lilly, Daiichi Sankyo, The Medicines Company, AstraZeneca, and Evolva

Recent Contributions to PracticeUpdate:

  1. Early Intervention Is Optimal in NSTE-ACS Without Pretreatment
  2. Aspirin Desensitization in Patients With CAD
  3. MY APPROACH to Choosing an ADP Inhibitor in Acute Coronary Syndrome
  4. Morphine Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With STEMI Undergoing Primary PCI
  5. MY APPROACH to Dual Antiplatelet Therapy After Elective PCI
  6. Optimal Platelet Inhibition in Non–ST-Elevation ACS

Most Read This Week

Recently Updated